Copyright Reports & Markets. All rights reserved.

Global AI Disease Detection Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of AI Disease Detection by Type
    • 1.3.1 Overview: Global AI Disease Detection Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global AI Disease Detection Consumption Value Market Share by Type in 2025
    • 1.3.3 Physical Ailment
    • 1.3.4 Mental Illness
  • 1.4 Global AI Disease Detection Market by Application
    • 1.4.1 Overview: Global AI Disease Detection Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Enterprise
    • 1.4.4 Individual
    • 1.4.5 Others
  • 1.5 Global AI Disease Detection Market Size & Forecast
  • 1.6 Global AI Disease Detection Market Size and Forecast by Region
    • 1.6.1 Global AI Disease Detection Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global AI Disease Detection Market Size by Region, (2021-2032)
    • 1.6.3 North America AI Disease Detection Market Size and Prospect (2021-2032)
    • 1.6.4 Europe AI Disease Detection Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific AI Disease Detection Market Size and Prospect (2021-2032)
    • 1.6.6 South America AI Disease Detection Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa AI Disease Detection Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Nuvoola
    • 2.1.1 Nuvoola Details
    • 2.1.2 Nuvoola Major Business
    • 2.1.3 Nuvoola AI Disease Detection Product and Solutions
    • 2.1.4 Nuvoola AI Disease Detection Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Nuvoola Recent Developments and Future Plans
  • 2.2 Oatmeal Health
    • 2.2.1 Oatmeal Health Details
    • 2.2.2 Oatmeal Health Major Business
    • 2.2.3 Oatmeal Health AI Disease Detection Product and Solutions
    • 2.2.4 Oatmeal Health AI Disease Detection Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Oatmeal Health Recent Developments and Future Plans
  • 2.3 NIRAMAI
    • 2.3.1 NIRAMAI Details
    • 2.3.2 NIRAMAI Major Business
    • 2.3.3 NIRAMAI AI Disease Detection Product and Solutions
    • 2.3.4 NIRAMAI AI Disease Detection Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 NIRAMAI Recent Developments and Future Plans
  • 2.4 iCAD
    • 2.4.1 iCAD Details
    • 2.4.2 iCAD Major Business
    • 2.4.3 iCAD AI Disease Detection Product and Solutions
    • 2.4.4 iCAD AI Disease Detection Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 iCAD Recent Developments and Future Plans
  • 2.5 MultiplAI Health
    • 2.5.1 MultiplAI Health Details
    • 2.5.2 MultiplAI Health Major Business
    • 2.5.3 MultiplAI Health AI Disease Detection Product and Solutions
    • 2.5.4 MultiplAI Health AI Disease Detection Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 MultiplAI Health Recent Developments and Future Plans
  • 2.6 Medicus AI
    • 2.6.1 Medicus AI Details
    • 2.6.2 Medicus AI Major Business
    • 2.6.3 Medicus AI AI Disease Detection Product and Solutions
    • 2.6.4 Medicus AI AI Disease Detection Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Medicus AI Recent Developments and Future Plans
  • 2.7 AEYE Health
    • 2.7.1 AEYE Health Details
    • 2.7.2 AEYE Health Major Business
    • 2.7.3 AEYE Health AI Disease Detection Product and Solutions
    • 2.7.4 AEYE Health AI Disease Detection Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 AEYE Health Recent Developments and Future Plans
  • 2.8 NURA
    • 2.8.1 NURA Details
    • 2.8.2 NURA Major Business
    • 2.8.3 NURA AI Disease Detection Product and Solutions
    • 2.8.4 NURA AI Disease Detection Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 NURA Recent Developments and Future Plans
  • 2.9 Kheiron
    • 2.9.1 Kheiron Details
    • 2.9.2 Kheiron Major Business
    • 2.9.3 Kheiron AI Disease Detection Product and Solutions
    • 2.9.4 Kheiron AI Disease Detection Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Kheiron Recent Developments and Future Plans
  • 2.10 Aidoc
    • 2.10.1 Aidoc Details
    • 2.10.2 Aidoc Major Business
    • 2.10.3 Aidoc AI Disease Detection Product and Solutions
    • 2.10.4 Aidoc AI Disease Detection Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Aidoc Recent Developments and Future Plans
  • 2.11 Aiberry
    • 2.11.1 Aiberry Details
    • 2.11.2 Aiberry Major Business
    • 2.11.3 Aiberry AI Disease Detection Product and Solutions
    • 2.11.4 Aiberry AI Disease Detection Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Aiberry Recent Developments and Future Plans
  • 2.12 Ellipsis Health
    • 2.12.1 Ellipsis Health Details
    • 2.12.2 Ellipsis Health Major Business
    • 2.12.3 Ellipsis Health AI Disease Detection Product and Solutions
    • 2.12.4 Ellipsis Health AI Disease Detection Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Ellipsis Health Recent Developments and Future Plans
  • 2.13 Omdena
    • 2.13.1 Omdena Details
    • 2.13.2 Omdena Major Business
    • 2.13.3 Omdena AI Disease Detection Product and Solutions
    • 2.13.4 Omdena AI Disease Detection Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Omdena Recent Developments and Future Plans
  • 2.14 Innowise Group
    • 2.14.1 Innowise Group Details
    • 2.14.2 Innowise Group Major Business
    • 2.14.3 Innowise Group AI Disease Detection Product and Solutions
    • 2.14.4 Innowise Group AI Disease Detection Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Innowise Group Recent Developments and Future Plans
  • 2.15 Syndell
    • 2.15.1 Syndell Details
    • 2.15.2 Syndell Major Business
    • 2.15.3 Syndell AI Disease Detection Product and Solutions
    • 2.15.4 Syndell AI Disease Detection Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Syndell Recent Developments and Future Plans
  • 2.16 Klizo Solutions
    • 2.16.1 Klizo Solutions Details
    • 2.16.2 Klizo Solutions Major Business
    • 2.16.3 Klizo Solutions AI Disease Detection Product and Solutions
    • 2.16.4 Klizo Solutions AI Disease Detection Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Klizo Solutions Recent Developments and Future Plans
  • 2.17 Wysa
    • 2.17.1 Wysa Details
    • 2.17.2 Wysa Major Business
    • 2.17.3 Wysa AI Disease Detection Product and Solutions
    • 2.17.4 Wysa AI Disease Detection Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Wysa Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global AI Disease Detection Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of AI Disease Detection by Company Revenue
    • 3.2.2 Top 3 AI Disease Detection Players Market Share in 2025
    • 3.2.3 Top 6 AI Disease Detection Players Market Share in 2025
  • 3.3 AI Disease Detection Market: Overall Company Footprint Analysis
    • 3.3.1 AI Disease Detection Market: Region Footprint
    • 3.3.2 AI Disease Detection Market: Company Product Type Footprint
    • 3.3.3 AI Disease Detection Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global AI Disease Detection Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global AI Disease Detection Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global AI Disease Detection Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global AI Disease Detection Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America AI Disease Detection Consumption Value by Type (2021-2032)
  • 6.2 North America AI Disease Detection Market Size by Application (2021-2032)
  • 6.3 North America AI Disease Detection Market Size by Country
    • 6.3.1 North America AI Disease Detection Consumption Value by Country (2021-2032)
    • 6.3.2 United States AI Disease Detection Market Size and Forecast (2021-2032)
    • 6.3.3 Canada AI Disease Detection Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico AI Disease Detection Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe AI Disease Detection Consumption Value by Type (2021-2032)
  • 7.2 Europe AI Disease Detection Consumption Value by Application (2021-2032)
  • 7.3 Europe AI Disease Detection Market Size by Country
    • 7.3.1 Europe AI Disease Detection Consumption Value by Country (2021-2032)
    • 7.3.2 Germany AI Disease Detection Market Size and Forecast (2021-2032)
    • 7.3.3 France AI Disease Detection Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom AI Disease Detection Market Size and Forecast (2021-2032)
    • 7.3.5 Russia AI Disease Detection Market Size and Forecast (2021-2032)
    • 7.3.6 Italy AI Disease Detection Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific AI Disease Detection Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific AI Disease Detection Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific AI Disease Detection Market Size by Region
    • 8.3.1 Asia-Pacific AI Disease Detection Consumption Value by Region (2021-2032)
    • 8.3.2 China AI Disease Detection Market Size and Forecast (2021-2032)
    • 8.3.3 Japan AI Disease Detection Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea AI Disease Detection Market Size and Forecast (2021-2032)
    • 8.3.5 India AI Disease Detection Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia AI Disease Detection Market Size and Forecast (2021-2032)
    • 8.3.7 Australia AI Disease Detection Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America AI Disease Detection Consumption Value by Type (2021-2032)
  • 9.2 South America AI Disease Detection Consumption Value by Application (2021-2032)
  • 9.3 South America AI Disease Detection Market Size by Country
    • 9.3.1 South America AI Disease Detection Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil AI Disease Detection Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina AI Disease Detection Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa AI Disease Detection Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa AI Disease Detection Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa AI Disease Detection Market Size by Country
    • 10.3.1 Middle East & Africa AI Disease Detection Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey AI Disease Detection Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia AI Disease Detection Market Size and Forecast (2021-2032)
    • 10.3.4 UAE AI Disease Detection Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 AI Disease Detection Market Drivers
  • 11.2 AI Disease Detection Market Restraints
  • 11.3 AI Disease Detection Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 AI Disease Detection Industry Chain
  • 12.2 AI Disease Detection Upstream Analysis
  • 12.3 AI Disease Detection Midstream Analysis
  • 12.4 AI Disease Detection Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global AI Disease Detection market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    AI disease detection refers to the use of artificial intelligence technology to analyze and detect various diseases and medical conditions. By utilizing machine learning algorithms and data analysis techniques, AI Disease Detection can assist in the interpretation of medical images, identification of disease biomarkers, analysis of patient data, and prediction of disease outcomes. It aims to support healthcare professionals in accurate and timely diagnosis, treatment planning, and disease management.
    This report is a detailed and comprehensive analysis for global AI Disease Detection market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global AI Disease Detection market size and forecasts, in consumption value ($ Million), 2021-2032
    Global AI Disease Detection market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global AI Disease Detection market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global AI Disease Detection market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for AI Disease Detection
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global AI Disease Detection market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Nuvoola, Oatmeal Health, NIRAMAI, iCAD, MultiplAI Health, Medicus AI, AEYE Health, NURA, Kheiron, Aidoc, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    AI Disease Detection market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Physical Ailment
    Mental Illness
    Market segment by Application
    Hospital
    Enterprise
    Individual
    Others
    Market segment by players, this report covers
    Nuvoola
    Oatmeal Health
    NIRAMAI
    iCAD
    MultiplAI Health
    Medicus AI
    AEYE Health
    NURA
    Kheiron
    Aidoc
    Aiberry
    Ellipsis Health
    Omdena
    Innowise Group
    Syndell
    Klizo Solutions
    Wysa
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe AI Disease Detection product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of AI Disease Detection, with revenue, gross margin, and global market share of AI Disease Detection from 2021 to 2026.
    Chapter 3, the AI Disease Detection competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and AI Disease Detection market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of AI Disease Detection.
    Chapter 13, to describe AI Disease Detection research findings and conclusion.

    Buy now